We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Cyclerion Therapeutics
CYCN
$14.9M
| $471K | ﹤0.01% |
8,663
-712
| -8% | -$66.5K |
|
702
IPG Photonics
IPGP
$3.61B
| $449K | ﹤0.01% |
3,100
-10,000
| -76% | -$1.39M |
|
703
Sprout Social
SPT
$516M
| $401K | ﹤0.01% |
+25,000
| New | +$406K |
|
704
UFP Industries
UFPI
$4.9B
| $396K | ﹤0.01% |
+8,310
| New | +$392K |
|
705
Garrett Motion
GTX
$5.81B
| $279K | ﹤0.01% |
27,919
| – | – |
|
706
Sutro Biopharma
STRO
$401M
| $275K | ﹤0.01% |
+2,500
| New | +$258K |
|
707
Nabors Industries
NBR
$1.27B
| $216K | ﹤0.01% |
1,500
| – | – |
|
708
Resideo Technologies
REZI
$5.19B
| $169K | ﹤0.01% |
14,180
| – | – |
|
|
ADXS
709
DELISTED
Advaxis Inc
ADXS
| $143K | ﹤0.01% |
166,666
| – | – |
|
|
VIA
710
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $124K | ﹤0.01% |
2,695
| – | – |
|
|
FTSI
711
DELISTED
FTS International, Inc. Common Stock
FTSI
| $68K | ﹤0.01% |
3,250
| – | – |
|
712
Alcoa
AA
$11.9B
| – | – |
-600,000
| Closed | -$12M |
|
713
AbbVie
ABBV
$443B
| – | – |
-1,037,161
| Closed | -$78.5M |
|
714
Affiliated Managers Group
AMG
$9.69B
| – | – |
-22,125
| Closed | -$1.84M |
|
715
AnaptysBio
ANAB
$1.58B
| – | – |
-2,695,922
| Closed | -$94.3M |
|
|
OPTU
716
Optimum Communications Inc
OPTU
$298M
| – | – |
-1,700,000
| Closed | -$48.8M |
|
717
Franklin Resources
BEN
$17.6B
| – | – |
-254,300
| Closed | -$7.34M |
|
718
BorgWarner
BWA
$13.1B
| – | – |
-283,659
| Closed | -$9.16M |
|
719
Century Aluminum
CENX
$4.43B
| – | – |
-300,000
| Closed | -$1.99M |
|
720
Cincinnati Financial
CINF
$27.3B
| – | – |
-6,700
| Closed | -$782K |
|
721
Cenovus Energy
CVE
$55.7B
| – | – |
-1,700,000
| Closed | -$15.9M |
|
722
Dell
DELL
$262B
| – | – |
-345,275
| Closed | -$9.08M |
|
723
Dow Inc
DOW
$21.9B
| – | – |
-703,899
| Closed | -$33.5M |
|
724
eBay
EBAY
$50.6B
| – | – |
-429,700
| Closed | -$16.8M |
|
725
Everest Group
EG
$14.5B
| – | – |
-7,299
| Closed | -$1.94M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.